Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside
about
The endocannabinoid system, cannabinoids, and painTaming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effectsCannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trialsIs lipid signaling through cannabinoid 2 receptors part of a protective system?Chemical probes of endocannabinoid metabolismInteraction between Cannabinoid System and Toll-Like Receptors Controls InflammationTherapeutic Effects of Phytochemicals and Medicinal Herbs on Chemotherapy-Induced Peripheral NeuropathyProtective effects of cannabidiol on lesion-induced intervertebral disc degenerationA new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis.Fatty acid amide hydrolase (FAAH) inhibitors exert pharmacological effects, but lack antinociceptive efficacy in rats with neuropathic spinal cord injury pain.Antinociceptive effects of racemic AM1241 and its chirally synthesized enantiomers: lack of dependence upon opioid receptor activation.Endocannabinoids Have Opposing Effects On Behavioral Responses To Nociceptive And Non-nociceptive Stimuli.Cannabinoid agonists inhibit neuropathic pain induced by brachial plexus avulsion in mice by affecting glial cells and MAP kinases.Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action.Celastrol attenuates inflammatory and neuropathic pain mediated by cannabinoid receptor type 2.Psychopharmacology of the endocannabinoids: far beyond anandamide.Fatty acid amide hydrolase and monoacylglycerol lipase inhibitors produce anti-allodynic effects in mice through distinct cannabinoid receptor mechanisms.Endocannabinoid involvement in endometriosis.Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system.Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models.Medical marijuana in neurology.Cannabidiol, a Major Non-Psychotropic Cannabis Constituent Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts.The cannabinoid type-1 receptor carboxyl-terminus, more than just a tail.Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice.The endocannabinoid system and cancer: therapeutic implication.Identification of essential cannabinoid-binding domains: structural insights into early dynamic events in receptor activationAttenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy.Activation of cannabinoid CB2 receptors reduces hyperalgesia in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.A novel substituted aminoquinoline selectively targets voltage-sensitive sodium channel isoforms and NMDA receptor subtypes and alleviates chronic inflammatory and neuropathic pain.Therapeutic modulation of cannabinoid lipid signaling: metabolic profiling of a novel antinociceptive cannabinoid-2 receptor agonistAlterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics folloLow-dose vaporized cannabis significantly improves neuropathic painCombined Treatment with Morphine and Δ9-Tetrahydrocannabinol in Rhesus Monkeys: Antinociceptive Tolerance and Withdrawal.Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2.Modulating the endocannabinoid system in human health and disease--successes and failuresDifferential modulation of nociceptive versus non-nociceptive synapses by endocannabinoids.Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokersCellular, molecular, and epigenetic mechanisms in non-associative conditioning: implications for pain and memoryA preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis
P2860
Q24601890-0F3A9CC5-2345-4950-AEB1-69B05EDAE6DFQ24606148-4F6092D4-C40E-4340-981B-55E5D54F1442Q24625489-3D16D24F-1094-4B4C-89F8-5669A8BC7F14Q24633122-B4E8A654-E393-4C1F-B4D9-5201B48BF377Q26863202-00866536-7D91-4522-A92C-6D89DC4A73F7Q28066215-7C1A3293-50DC-400F-B89D-0E4DFF7B6075Q28075341-BD6758AC-F93D-4132-982A-D2467D8B8CFBQ28542740-7593E4E4-1E9C-424C-99C7-12D0D96C74ABQ30670447-5BF71AA6-0F10-4ADA-9F18-7A11F002D777Q33560467-4A0426A9-D1C4-435D-B795-A0C6A551D7F3Q33749455-AABC6845-3541-4EF3-B400-E25950FC98C3Q33919139-CDFBEF5A-EE31-41E9-90B6-FB8D8F08F672Q34023238-DB54C4E1-2D4E-421D-9B29-124100D22836Q34143222-D08D215F-6D64-4F81-9835-3BCBB1D6C841Q34158418-C7E291D4-E6F0-4C3A-842B-EE4E634C2774Q34190754-8CCF7BF3-B63B-4735-AE51-1CFE82328F9CQ34231719-66FD9083-AB57-4124-AD05-82F6467F8A8FQ34274062-3DD757AD-F7D4-4727-9BA3-131AE9C48CBAQ34294075-B58F5C37-3EB1-4D0E-A264-055E89F86F94Q34390806-AAFF1785-B78B-4D7D-B78C-7FEFFED09793Q34449698-A19FFB6E-B8EB-4059-BCDA-4BBE2C5B6C29Q34468292-662D81A7-1A0B-48F9-AE6D-C6F302CE0E4DQ34663357-F68D2C63-2786-4F02-ABD3-500B5EB5F3FFQ34898890-CDBDC5C4-1487-4D38-8EB4-B8BC3ACBE131Q35189004-9688AE75-38B1-4526-A115-479BCACB80BDQ35193299-75193CE4-A566-4490-9B04-81A10AA20F86Q35312313-696D544E-1790-4AB3-B069-DC4A09113A33Q35689152-EF7E2488-EE5F-46D9-BC36-96F9222B28F6Q35731427-8C3C8275-B8C6-4498-A674-99DF215AD87AQ36011829-FF98E943-A4DA-49B0-B879-06A3FC941B06Q36385052-A6FADD42-4622-425B-8D8B-AD22A2B35A9EQ36476481-3F80E109-5F12-4090-8930-6EA6C6A37F67Q36593518-E0A0980C-8EB2-4471-9D98-4F5046DA3C68Q36852565-2F96EE1B-38A9-4A1F-81A9-B7F125CBD266Q36916261-C732B1C8-589D-4246-B279-72D12DF29FA2Q36933683-4FF065B7-6DE4-401E-B57A-9138C371AEF5Q36958407-A3CA300C-F843-465F-AED9-1554E5E35E1AQ37103395-23854A35-D4B2-40A5-9A9D-3A00CBB91B7AQ37161143-396059A7-2371-47F7-A4F5-0C98913B9023Q37235187-C77FD323-B357-4240-B71B-E3D25D172854
P2860
Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside
@ast
Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside
@en
Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside
@nl
type
label
Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside
@ast
Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside
@en
Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside
@nl
prefLabel
Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside
@ast
Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside
@en
Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside
@nl
P2860
P921
P1433
P1476
Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside
@en
P2093
Andrea G Hohmann
Elizabeth J Rahn
P2860
P2888
P304
P356
10.1016/J.NURT.2009.08.002
P577
2009-10-01T00:00:00Z
P5875
P6179
1029470976